Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Resources › Webinars › Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules
November 15, 2018

Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

Genome Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In PCR

  1. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  2. FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

  3. BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

  4. Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

  5. Becton Dickinson Preliminary Fiscal Q1 Revenues Rise 26 Percent, Firm Raises Guidance

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.